|Bid||86.39 x 100|
|Ask||86.53 x 300|
|Day's Range||85.90 - 86.85|
|52 Week Range||70.48 - 104.71|
|PE Ratio (TTM)||13.92|
|Earnings Date||Feb 12, 2018 - Feb 16, 2018|
|Forward Dividend & Yield||0.00 (0.00%)|
|1y Target Est||97.00|
Masimo (MASI) states that with its inherent touchscreen interface, Rad-97 is user-friendly for clinicians and non-clinicians and can be easily tailored to cater to the needs of home users.
Masimo announced today FDA clearance for home use of the Rad-97™ Pulse CO-Oximeter®. Rad-97 offers Masimo noninvasive and continuous monitoring, through Measure-through Motion and Low Perfusion™ SET® pulse oximetry and upgradeable rainbow® technologies, in a compact, standalone monitor that combines advanced connectivity and communication capabilities for telehealth with an interface easily customized ...
Masimo today announced that its management is scheduled to present at the 36th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Tuesday, January 9, 2018 at 5:00 p.m.
Masimo announced today the CE marking and release of RD rainbow Lite SET™ sensors, which enable the monitoring of Masimo Oxygen Reserve Index™ and RPVi™, an improved PVi® that allows clinicians to assess fluid responsiveness noninvasively and continuously1 at a fraction of the cost of invasive methods, and at a fraction of the cost of rainbow® sensors.
Cogentix Medical (CGNT) stock continues to hover around the 52-week high mark reached on Dec 27, courtesy of its new strategies.
Edwards Lifesciences' (EW) pipeline building to fortify foothold across all operating businesses bodes well. Also, the TAVR adoption rate across Japan and the European countries is impressive.
Align (ALGN) gains from balanced sales growth across all its channels of late, primarily on high InvisAlign Technology case volumes.
Stock Monitor: AcelRx Pharma Post Earnings Reporting LONDON, UK / ACCESSWIRE / December 08, 2017 / Active-Investors free earnings report on Masimo Corp. (NASDAQ: MASI ) has freshly been issued to its members, ...
NEW YORK, Dec. 04, 2017-- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of ...
Masimo announced today that Artemis Hospital, one of the leading multi-specialty hospitals in the Delhi-NCR region of India, is adopting Masimo Patient SafetyNet™*, a supplemental remote monitoring and clinician notification system, across all hospital care areas.
The Zacks Analyst Blog Highlights: IDEXX Laboratories, Luminex, Masimo, Align Technology and Cooper Companies
Trump's tax reform policies promise to cut corporate taxes. However, the future of the U.S. MedTech industry depends on the much-awaited decision on the 2.3% medical device tax.
Masimo announced today FDA clearance and U.S. release of the full family of NomoLine™ capnography sampling lines. NomoLine sampling lines are available in more than 40 configurations of airway adapter sets and cannulas for use in a variety of clinical scenarios, including for intubated and non-intubated patients in both low and high humidity applications, for all patient populations, including neonatal ...
In conjunction with World Pneumonia Day on Sunday, November 12, Masimo announced its continuing efforts to help combat the global burden of pneumonia.
Research Desk Line-up: Masimo Post Earnings Coverage LONDON, UK / ACCESSWIRE / November 8, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on NuVasive, Inc. (NASDAQ: NUVA ), which ...
Masimo today announced that its management is scheduled to present at the Stifel 2017 Healthcare Conference at the Palace Hotel in New York on Tuesday, November 14, 2017 at 9:30 a.m.
Masimo announced today that The Jeffrey Lee Williams Foundation has distributed 20 Masimo Rad-57® Pulse CO-Oximeters® to EMS departments in York County, South Carolina, with the majority going to Piedmont Medical Center EMS.
Strong demand for its pulse oximeters give the maker of non-invasive monitoring technologies another impressive quarter.
NEW YORK, NY / ACCESSWIRE / October 31, 2017 / Masimo Corporation (NASDAQ: MASI ) will be discussing their earnings results in their Q3 Earnings Call to be held on October 3, 2017 at 4:30 PM Eastern Time. ...